Chow Kenneth W, Cumpian Nicholas A, Makar Ranjit, Zargar Pejman, Oza Fouzia, Suliman Idrees, Eysselein Viktor, Reicher Sofiya
Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Division of Gastroenterology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Diagnostics (Basel). 2024 Dec 18;14(24):2854. doi: 10.3390/diagnostics14242854.
Lumen-apposing metal stents (LAMS) are utilized in a wide range of therapeutic gastrointestinal applications. We present our experience with LAMS-assisted drainage of complex pelvic abscesses at a large safety-net hospital.
EUS-guided LAMS placements for pelvic abscesses from July 2020 to June 2024 were analyzed. Data were collected on patient demographics, procedure indications, fluid collection size, stent characteristics, stent dwell time, and complications. All cases underwent multidisciplinary review with Surgery and Interventional Radiology (IR) prior to LAMS-assisted drainage; all were deemed not amenable to drainage by IR.
Eleven patients underwent EUS-guided drainage of complex pelvic abscesses with cautery-enhanced LAMS. Diverticulitis was the most common cause of abscesses (n = 6; 55%). The average time from presentation to drainage was 7 days (1-18). The average abscess size was 7.2 cm (3.9-12.0 cm). The most common LAMS size was 15 mm × 10 mm; each was placed through the left colon and rectum with both technical and clinical success. All abscesses completely resolved with a mean stent dwell time of 28 days (17-42 days). After stent removal, the fistula was not routinely closed. No complications such as stent migration, bleeding, or perforation occurred. There were no recurrences and no patients required additional surgical or IR procedures with a mean follow-up of 25 weeks (SD 35.6).
Adequate drainage is the cornerstone of pelvic abscess management, but IR or surgical access can be challenging, with inadequate drainage and prolonged hospitalization leading to significant morbidity. In our experience, EUS-guided, LAMS-assisted drainage provides a safe and effective alternative for managing pelvic abscesses.
管腔对合金属支架(LAMS)被广泛应用于多种胃肠道治疗。我们介绍了在一家大型安全网医院使用LAMS辅助引流复杂盆腔脓肿的经验。
分析2020年7月至2024年6月期间因盆腔脓肿行超声内镜引导下LAMS置入术的病例。收集患者人口统计学资料、手术指征、积液大小、支架特征、支架留置时间和并发症等数据。所有病例在LAMS辅助引流前均接受了外科和介入放射学(IR)的多学科评估;所有病例均被IR认为不适合引流。
11例患者接受了超声内镜引导下使用烧灼增强型LAMS引流复杂盆腔脓肿。憩室炎是脓肿最常见的病因(n = 6;55%)。从出现症状到引流的平均时间为7天(1 - 18天)。脓肿平均大小为7.2 cm(3.9 - 12.0 cm)。最常用的LAMS尺寸为15 mm×10 mm;每个支架均通过左结肠和直肠置入,技术和临床均成功。所有脓肿均完全消退,支架平均留置时间为28天(17 - 42天)。支架取出后,瘘管未常规闭合。未发生支架移位、出血或穿孔等并发症。无复发情况,平均随访25周(标准差35.6),无患者需要额外的手术或IR操作。
充分引流是盆腔脓肿治疗的基石,但IR或手术引流可能具有挑战性,引流不充分和住院时间延长会导致显著的发病率。根据我们的经验,超声内镜引导下LAMS辅助引流为盆腔脓肿的治疗提供了一种安全有效的替代方法。